Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients

Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients

Background and objectives: The short-term reported antibody response to SARS-COV-2 vaccination in dialysis patients is high, with a seroconversion response rate up to 97%. Data on the long-term durability of this response are scarce. Our objective was to characterize the long-term anti-spike antibod...

Full description

Bibliographic Details
Main Authors: Noa Berar-Yanay, Sarit Freiman, Maʹanit Shapira, Amer Saffoury, Ameer Elemy, Munir Hamze, Mohamad Elhaj, Maha Zaher, Loai Matanis, Zaher Anis Armaly
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
SAR S-COV-2
BNT162b2 mRNA vaccine
end stage renal disease
dialysis
waning
Online Access:https://www.mdpi.com/2077-0383/11/1/64

Internet

https://www.mdpi.com/2077-0383/11/1/64

Similar Items